Navigation Links
XBiotech Reports Positive Phase II Interim Analysis Results in Vascular Disease
Date:11/20/2012

le and safe monoclonal antibody therapy into current treatment practices has the potential to provide significant benefit to patients and a new option for endovascular surgeons."

"Vascular inflammation is the cause of vascular diseases such as atherosclerosis," said Michael Stecher, M.D., Medical Director, XBiotech. "Our MABp1 therapy blocks a key mediator of vascular inflammation. Patients with advanced arterial disease treated with MABp1 after revascularization have shown reduced arterial occlusion and reduced overall complications from the disease.  Based on the interim results, we believe MABp1 may ultimately provide a treatment for millions of patients suffering with vascular disease."

About True Human™ Antibodies

True Human™ antibodies represent the next generation of therapeutic antibodies.  These antibodies are identified using the Company's proprietary platform technology to ensure faithful reproduction of the original human antibody gene.  True Human antibodies are "invisible" to the body's immune system and thus have the potential for better safety, efficacy and patient tolerability compared to earlier generation antibody therapeutics.

About XBiotech

XBiotech is pioneering breakthrough therapies that improve the safety and efficacy of antibody therapeutics. The Company's lead product candidate inhibits chronic sterile inflammation by targeting IL-1a, a master regulator of inflammation. The clinical development program addresses tremendous unmet medical need in multiple disease indications including, acne, psoriasis, cachexia, cancer, type 2 diabetes and cardiovascular disease. XBiotech is also revolutionizing scalable, flexible manufacturing systems for the production of biological therapies.  Using minimal infrastructure and disposable bioreactor technology – to dramatically reduce capital requirements, operating complexity, and lead times -
'/>"/>

SOURCE XBiotech
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. XBiotech Reports Positive Phase II Interim Analysis Results From Type 2 Diabetes Study
2. Regulus Reports Third Quarter 2012 Financial Results and Recent Highlights
3. Grupo Casa Saba Reports - Grupo Casa Saba Announces its Intention to Delist From the New York Stock Exchange
4. Solos Endoscopy Reports Book Value of $2,393,522 for Period Ended September 30, 2012
5. ULURU Inc. Reports Third Quarter 2012 Financial Results
6. Simcere Pharmaceutical Group Reports Preliminary Unaudited Third Quarter 2012 Results
7. China Pharma Holdings, Inc. Reports Third Quarter 2012 Financial Results
8. OncoSec Medical Reports Positive Preliminary Efficacy Results from Phase II Study of ImmunoPulse in Metastatic Melanoma Patients
9. Sinovac Reports Unaudited Third Quarter 2012 Financial Results
10. TPI Reports First Quarter Fiscal Year 2013 Financial Results
11. Cardium Presents Third Quarter 2012 Financial Results and Reports on Recent Developments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... LOS ANGELES , Oct. 29, 2014 /PRNewswire/ ... pharmaceutical company devoted to bringing new products to ... 2015. ViaDerma has developed an innovative, ... for rapid mass transfer of pharmaceutical active ingredients ... to provide immediate localized therapy. The transdermal delivery ...
(Date:10/30/2014)... Oct. 30, 2014 Today Eli Lilly and ... its long-standing technology transfer program to increase the global ... 2003, the effort included Lilly donating manufacturing technology and ... China , India , ... Africa – all MDR-TB ,hot spots., It ...
(Date:10/27/2014)... , Oct. 27, 2014  Demonstrations by ... devices are being featured this week in ... Scientific Assembly where more than 7,000 emergency physicians ... and participating in educational courses. These ... drop of true-to-life emergency department environments, including three ...
Breaking Medicine Technology:ViaDerma, Inc. Announces Plans to Pursue Out-Licensing Partnerships in 2015 2ViaDerma, Inc. Announces Plans to Pursue Out-Licensing Partnerships in 2015 3Lilly Shares Insights from Decade-Long Technology Transfer Experience 2Lilly Shares Insights from Decade-Long Technology Transfer Experience 3Lilly Shares Insights from Decade-Long Technology Transfer Experience 4Emergency Medicine of the Future Demonstrated at ACEP14 2Emergency Medicine of the Future Demonstrated at ACEP14 3Emergency Medicine of the Future Demonstrated at ACEP14 4Emergency Medicine of the Future Demonstrated at ACEP14 5Emergency Medicine of the Future Demonstrated at ACEP14 6Emergency Medicine of the Future Demonstrated at ACEP14 7Emergency Medicine of the Future Demonstrated at ACEP14 8Emergency Medicine of the Future Demonstrated at ACEP14 9Emergency Medicine of the Future Demonstrated at ACEP14 10Emergency Medicine of the Future Demonstrated at ACEP14 11Emergency Medicine of the Future Demonstrated at ACEP14 12Emergency Medicine of the Future Demonstrated at ACEP14 13Emergency Medicine of the Future Demonstrated at ACEP14 14Emergency Medicine of the Future Demonstrated at ACEP14 15
(Date:10/30/2014)... Sound Telecom, a leader in the call center industry, just ... they wonder, “Should I use an answering service?” The graphic ... a series of yes or no questions that ultimately ends ... many considerations and scenarios that come into play when deciding ... This decision infographic serves as a bit of a map ...
(Date:10/30/2014)... -- Scientists who used stem cells to create miniature ... provide a new way to learn more about the ... used human pluripotent stem cells -- which can become ... grow the functional miniature stomachs, to study infection by ... ulcers and stomach cancer. The miniature stomachs offer ...
(Date:10/30/2014)... Thompson HealthDay Reporter WEDNESDAY, ... could be bad for your health, a new study reports. ... can help strengthen bones and prevent osteoporosis. These benefits to ... as part of a healthy diet. But this new ... protect men or women from bone fractures, and was linked ...
(Date:10/30/2014)... WEDNESDAY, Oct. 29, 2014 (HealthDay News) -- Eating a ... difficult to treat, according to new research. ... or modified Atkins diet, that focuses on foods like ... could help reduce seizures in adults whose condition doesn,t ... the 35 percent of people with epilepsy whose seizures ...
(Date:10/30/2014)... -- A new vaccine that could help prevent some ... the U.S. Food and Drug Administration on Wednesday. ... of 10 and 25 from invasive meningococcal disease caused ... The bacteria can infect the bloodstream (sepsis) and the ... is a leading cause of bacterial meningitis, and infection ...
Breaking Medicine News(10 mins):Health News:Sound Telecom Produces Decision Infographic to Aid Businesses 2Health News:Is Milk Your Friend or Foe? 2Health News:Is Milk Your Friend or Foe? 3Health News:High-Fat, Low-Carb Diet May Help With Tough-to-Treat Epilepsy 2Health News:High-Fat, Low-Carb Diet May Help With Tough-to-Treat Epilepsy 3Health News:FDA Approves New Vaccine to Protect Against Meningitis 2
... Sri Ravishankar has said practising yoga, pranayam and meditation will ... // ,'Youths crave for something different and it ... to them,' he said while interacting with reporters last evening ... km from here., ,Ravi Shankar appealed to the youths ...
... to the researchers at the Harvard Medical School it is ... of chronically infected cystic fibrosis (CF) patients. // Pseudomonas aeruginosa ... in the CF patients says Joseph Mougous, lead author of ... ‘In the case of Pseudomonas aeruginosa, the host may be ...
... became orphaned after their HIV-infected parents died four years ... at a function here tomorrow.// ,The function, ... care of the children's health, education and welfare, would ... K Sreemati, who at a recent Cabinet meeting mooted ...
... and lung cancer has now been found to cause ... Institute of Medicine revealed this finding in its report. ... but not sufficient’ evidence to point out conclude mineral ... cancer. However there was insufficient evidence to relate asbestos ...
... A new US government report has found that risky health ... rash motor vehicle driving are declining among the American youth ... trend needs to be steeper and the disparities between racial ... ,As director of the division of adolescent and school health ...
... at the Johns Hopkins Bloomberg School of Public Health ... ward off bacterial// pathogens and plasmodium parasites. The study ... proteins in the immune system of mosquitoes. ... limiting infection by the malaria parasites were also important ...
Cached Medicine News:Health News:Treatment of Bacterial Infection Paves the Way to Treat CF Infection 2Health News:Laryngeal Cancer Added to Asbestos’ Crime Lis 2Health News:US Teens turn Wiser to Risky Behavior 2Health News:US Teens turn Wiser to Risky Behavior 3Health News:What Ticks the Mosquito immune system? 2
Pipetman P is a fully adjustable, air-displacement pipette with the selected volume shown on a digital indicator (volumeter). Eight models cover the full range of volumes from 0.2 L to 10 mL....
... Since 1991 Intersurgical Incorporated ... filters, heat and moisture ... therapy products, hand-held nebulizers ... of accessories and connectors ...
Research Series 2100 Adjustable-volume Pipette, 2.0-20 l, single-channel with adjustable-volume setting...
The Leader in ICU Humidification., ,Available Configurations: , Gas Sampling Port, Straight Flex Tube, Poppel Flex Tube, Luer Port for Pressure, Monitoring/Secretion Removal, Special Use Devices, M...
Medicine Products: